Syndax Pharmaceuticals (SNDX) Treasury Shares (2016 - 2025)

Syndax Pharmaceuticals' Treasury Shares history runs 7 years deep, the most recent figure standing at $2.6 million for Q4 2025.

• In Q4 2025, Treasury Shares rose 100.72% year-over-year to $2.6 million; the TTM figure through Dec 2025 stood at $2.6 million (up 100.72% YoY), while the FY2025 annual figure was $2.6 million, up 100.72% from the prior year.
• Treasury Shares was $2.6 million for Q4 2025 at Syndax Pharmaceuticals, up from $1.3 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $2.6 million in Q4 2025 to a low of $132333.0 in Q4 2021.
• Historically, Treasury Shares has averaged $634897.7 across 5 years, with a median of $392288.0 in 2023.
• The sharpest annual moves came in 2021 and 2023: Treasury Shares jumped 615.31% in 2021, then soared 52.89% in 2023.
• A 5-year view of Treasury Shares shows it stood at $132333.0 in 2021, then surged by 69.87% to $224788.0 in 2022, then jumped by 131.08% to $519436.0 in 2023, then soared by 151.06% to $1.3 million in 2024, then soared by 100.72% to $2.6 million in 2025.
• The last three Treasury Shares figures came in at $2.6 million (Q4 2025), $1.3 million (Q4 2024), and $519436.0 (Q4 2023), per Business Quant data.